» Articles » PMID: 36494661

Low Incidence of Pelvic Sepsis Following Hartmann's Procedure for Rectal Cancer: a Retrospective Multicentre Study

Overview
Journal BMC Surg
Publisher Biomed Central
Specialty General Surgery
Date 2022 Dec 9
PMID 36494661
Authors
Affiliations
Soon will be listed here.
Abstract

Background: Results of previous studies regarding pelvic sepsis after Hartmann's procedure (HP) for rectal cancer have been inconsistent and few studies report the risk factors. This study aimed to investigate the incidence of pelvic sepsis after HP, identify risk factors and describe when as well as how pelvic sepsis was diagnosed and treated.

Methods: Data were collected from the Swedish Colorectal Cancer Registry on all patients undergoing HP for rectal cancer in the county of Skåne from 2007-2017. Patients diagnosed with pelvic sepsis were compared with patients without pelvic sepsis and risk factors for developing pelvic sepsis were analysed in a multivariable model.

Results: A total of 252 patients were included in the study, with 149 (59%) males, and a median age of 75 years (range 20-92). Altogether, 27 patients (11%) were diagnosed with pelvic sepsis. Risk factors for developing pelvic sepsis were neoadjuvant radiotherapy (OR 7.96, 95% CI 2.54-35.36) and BMI over 25 kg/m (OR 5.26, 95% CI 1.80-19.50). Median time from operation to diagnosis was 21 days (range 5-355) with 11 (40%) patients diagnosed beyond 30 days postoperatively. The majority of cases 19 (70%) were treated conservatively and none needed major surgery.

Conclusion: Pelvic sepsis occurred in 11% of patients. Neoadjuvant radiotherapy and higher BMI were significant risk factors for developing pelvic sepsis. Forty percent of patients were diagnosed later than 30 days postoperatively and most patients were successfully treated conservatively. Our findings suggest that HP is a valid treatment option for rectal cancer when anastomosis is inappropriate, even in patients receiving neoadjuvant radiotherapy.

Citing Articles

Hartmann's procedure in rectal cancer surgery is often an intraoperative decision: a retrospective multicenter study.

Mariusdottir E, Jorgren F, Saeed M, Wikstrom J, Lydrup M, Buchwald P Langenbecks Arch Surg. 2024; 409(1):55.

PMID: 38321307 PMC: 10847187. DOI: 10.1007/s00423-024-03237-8.

References
1.
Smedh K, Sverrisson I, Chabok A, Nikberg M . Hartmann's procedure vs abdominoperineal resection with intersphincteric dissection in patients with rectal cancer: a randomized multicentre trial (HAPIrect). BMC Surg. 2016; 16(1):43. PMC: 4940760. DOI: 10.1186/s12893-016-0161-2. View

2.
Frye J, Carne P, Robertson G, Frizelle F . Abdominoperineal resection or low Hartmann's procedure. ANZ J Surg. 2004; 74(7):537-40. DOI: 10.1111/j.1445-2197.2004.03055.x. View

3.
Popiolek M, Dehlaghi K, Gadan S, Baban B, Matthiessen P . Total Mesorectal Excision for Mid-Rectal Cancer Without Anastomosis: Low Hartmann's Operation or Intersphincteric Abdomino-Perineal Excision?. Scand J Surg. 2018; 108(3):233-240. DOI: 10.1177/1457496918812219. View

4.
Musters G, Buskens C, Bemelman W, Tanis P . Perineal wound healing after abdominoperineal resection for rectal cancer: a systematic review and meta-analysis. Dis Colon Rectum. 2014; 57(9):1129-39. DOI: 10.1097/DCR.0000000000000182. View

5.
Tottrup A, Frost L . Pelvic sepsis after extended Hartmann's procedure. Dis Colon Rectum. 2005; 48(2):251-5. DOI: 10.1007/s10350-004-0767-9. View